1. Introduction
Human life depends on our body’s metabolic processes, equilibrium, and optimally performing repair systems. Free radicals are chemical entities that are reactive and have one or more unpaired electrons. Free oxygen radicals play a vital part in our bodies normal functioning [
1,
2,
3]. In vivo, these have been developed as part of metabolism and have little sensitivity, and are capable of attacking DNA, proteins and fatty acids [
4], which can contribute to oxidative stress, and thus is the cause of many human physical abnormalities. On the other hand, O
2 possesses a dual face; it serves as a cause of reacting O
2/N
2 species (ROS/RNS) that in excesses can cause major health problems [
5,
6,
7,
8], as well as central nervous system neurodegeneration, such as Alzheimer’s disease [
9] and aging [
10,
11,
12]. It is commonly understood that oxygen is required for the process of breathing and that its absence is associated with death. All of our biological processes are guided by proper oxygen oxidation [
13,
14]. (ROS/RNS) species are defined chemically as particles containing at least one unpaired electron [
15]. Antioxidants are chemical substances that, while found in low doses compared to that of an oxygen electrode, can delay or prevent oxidation [
16]. Antioxidants are the body’s natural first line of defense against dangerous chemicals identified as free radicals, and they must respond quickly to free radicals to stop biomolecules from getting damaged. With greater exposure to free radicals, the requirement for antioxidants becomes even more crucial. Free radical exposure can be increased by pollution, cigarette smoke, medications, sickness, stress, and even exercise [
17]. Body cells manufacture them in reaction to free radicals [
18,
19,
20,
21]. Antioxidants are commonly utilized as catalysts in antibiotics for anti-inflammatory, antifungal, antibacterial, and antiviral purposes, as well as in the industry for anticorrosion [
22]. Organic compounds are a subclass of ligands that contain a variety of donor orbitals and exhibit attractive coordination configurations with metals [
23]. Organic compounds were frequently employed as ligands due to their high stability and solubility in common solvents such as EtOH, MeOH, CHCl
3, and DMF. The type of functional group linked with aromatic organic rings determines their biological activity. Organic molecules, as well as their metallic complexes, have been increasingly important in recent years due to their exceptional living uses [
24,
25]; anticancer [
26,
27], antibacterial [
28], antitumor [
29], antifertility and antifungal [
30], antioxidant [
29], herbicidal [
31,
32], and ant-proliferative [
33] properties are among the intrinsic biological actions of these substances. Furthermore, organic ligands have photoluminescence [
34], fluorescence [
35], potentiometric action caring [
36], anthelmintic [
37], and aggregation [
38] capabilities. Aromatic compounds are simple to synthesize and can bind to a wide range of metal ions through various oxidation states and symmetries [
39,
40]. Their complexes are recognized as including some of the most vital stereo-chemical modeling techniques throughout the main group and transition metal-ligand chemistry [
41] because of their preparative availability and physical variety. However, the binding of metal ions with these compounds seems to have a huge spectrum of applications in analytical chemistry, the food industry, the dye industry, catalysis, fungicidal, agrochemical, and biological activities, as well as a slight decrease in the cytotoxicity from both ions and Aryl ring [
42,
43,
44,
45,
46]. The investigation of metal-derived antioxidants has garnered considerable care and power in an attempt to generate compounds with great potential for scavenging free radicals linked with several ailments and diseases induced through ROS. Synthetic antioxidants are now commonly employed since they are more effective and less expensive than natural antioxidants. Several Schiff-base metal chelates are currently being studied as potent ROS scavengers and antioxidants [
47,
48]. Until now, no extensive reports on the antioxidant abilities of Schiff bases, and their potential metallic chelates, have been published. According to the results, it is necessary to investigate new antioxidants that can work inside an organism’s defense based on their chemical structure and unique replacement patterns that include both ROS deactivation and suppression of their formation.
2. Free Radicals & Antioxidants
Radicals are reactive chemical units that are reactive and also have one or more unpaired electrons. In vitro tests have been generated as a portion of cellular metabolism and have no specificity, attacking DNA, peptides, and fatty acids [
49], as well as being linked to diseases such as cancer and vascular disease [
50,
51], and pathological processes of the nervous system including Alzheimer’s disease [
49,
52] and growing older [
53]. Antioxidants are organic molecules that, once supplied for low quantities associated with those found in an oxygen electrode substrate, can retard or prevent degradation [
54]. In contrast to an antioxidant, which protects the neutral substrate from oxidation, a radical is a reduced living species. Antioxidants react by inhibiting or avoiding other compounds from decaying. The early studies on the function of antioxidants in genetics concentrated on their effectiveness in reducing oxidative degradation of cellular membranes [
55,
56,
57]. However, the findings of vitamins E, C and A [
58], as well as the explanation of the mechanism for oxidative stress prevention by vitamin E [
59], were watershed moments in comprehending the role of antioxidants in living beings. Antioxidants are typically divided into two types: non-enzymatic and enzymatic. They include numerous compounds with various sites of action and modes, as well as various final effects. This variety provides each of them with particular role functions within the body. It must be noted that the system for cooperating antioxidative enzymes, such as glutathione reductase (GRd), superoxide dismutase enzymes (SODs), glutathione peroxidase (GPx) and catalase (CAT), provides the most effective antioxidant defense [
60]. Low-molecular-weight antioxidants, such as coenzyme Q, vitamin C, E, carotenoids, microelements, and glutamine, are also involved in aggressive radical inactivation. Some of them are produced by the body, such as ubiquinone, glutamate, albumin, metallothioneins, and uric acid [
61], but the majority are external compounds that come from nature, including plants (carotenoids, flavonoids, coumarins, stilbenes, phenolic acids, lignans, vitamins, and organosulfur molecules) and minerals (Se, Mn, and Zn). As endogenous antioxidants engaged in free radical protection are unable to shield the body from ROS, exogenous antioxidants are required. Dietary supplements can also be used to supply antioxidants to the body. Synthetic antioxidants are bioequivalent to natural antioxidants; for example, bio vitamin C vs. chemically manufactured L-ascorbic acid, or synthetic and natural R, R-α-tocopherol. Antioxidants are also utilized as additives in the food, cosmetic, and pharmaceutical industries to keep unstable compounds from oxidizing. This mainly applies to phenolic-structured synthetic antioxidants used in food, such as BHT [butylated hydrotoluene], BHA [butylated hydroanisole], and TBHQ [tert-butylated hydroquinone] [
62]. Antioxidants vary in their capacity to neutralize free radicals. It has been demonstrated that antioxidant potential is highly associated with the number of powerful groups, such as NH
2, OH, and the position of each group in the series to meta < para < ortho, starting with the most active and progressing toward the least active [
63]. It emphasized that antioxidants can perform a variety of processes, not only scavenging radicals but also separating metal ions decaying H
2O
2 or hydroperoxides, softening aggressive pro-oxidants, and boosting endogenous antioxidant effects, such as fixing the resulting cellular destruction. Therefore, antioxidants are often categorized as principal or sequence-flouting antioxidants and intermediate or preventing antioxidants [
64]. Main antioxidants effectually stop the oxidation process through sequestering ROS/RNS, whereas 2nd antioxidants operate implicitly via coordination through metal (iron) ions [
65,
66] as well as extra detailed activities such as the initiation of protective parameters, anti-inflammatory suppression of NADPH oxidase [nicotinamide adenine dinucleotide phosphate oxidase], inhibition of xanthine oxidase, and regulation of extracellular antioxidants’ potential in avoiding or delaying oxidative stress is being more debated. The original optimism for their good health impacts was based primarily upon in vitro studies. The first investigations ignored the antioxidants’ in vivo bioavailability, which was often fairly poor. The antioxidant’s significant in vitro organic compounds reactivity is thus not indicative of its efficiency in vivo. Furthermore, as demonstrated by independent reviews [
67,
68], antioxidant medication may be ineffective and even hazardous. Relevant results on alternative action mechanisms of antioxidant compounds are included in the article of Hrelia and Angeloni [
69]. Their research demonstrates that natural antioxidants are extensively digested in vivo, causing their oxidation potential to decline significantly at the structural level. The researchers noted an increasing scholarly interest in the relations of natural antioxidants and proteins implicated in the intracellular signaling cascades, as well as gut macrobiotic regulation. Currently, in natural antioxidant research, (i) combination therapies that use the synergistic impact of naturally occurring antioxidants, (ii) anti-aging influence of fermented planning and preparation, (iii) enzymatic study, (iv) genome sequencing, (v) studies of the impact of antioxidant activity on the intestinal microbiota, and (vi) research on the determinants of antioxidants on the immune system are descriptions of research problems.
4. Metal Chelates with Antioxidant Properties
The synthetic features for metal structures may plan to employ various metals and ligands, consequently enabling its progress for detailed uses. The production and estimation of the performance of chelates as physiologically active ligands has increased in popularity over time [
82,
83,
84]. Combining redox characteristics for metal ions and various ligands is a viable technique for developing antioxidant molecules with several modes of action [
85,
86]. In general, antioxidants that promote the defense against free radicals in the body are typically obtained via dietary consumption [
87]. Organic substances with strong antioxidant capacity, such as flavones, flavonoids, phenolic acids, and cinnamic acids, are abundant in seeds, fruits, vegetables, wine, and tea, among other natural products [
88,
89]. Such antioxidants have a COOH or OH, and an oxo group for flavonoids and flavones, in their structural system, as well the ability to coordinate towards various metal ions and developing stable chelates, because most of these materials are associated with the metal as chelates via oxygen atom complexion [
85,
90]. Complex formation through natural products is favored towards elements with lower oxidation and spins levels, because the occurrence of phenyl ring through (1) or (2) chains in its molecules allows bond-strengthening back donation. Molecular coordination for the antioxidant ligand to a central metal ion enables the control of all features through the following benefits: (1) complexation for the substituent of control solubility, and (2) stability through the phenoxyl intermediate, produced in the substituent electrochemical process with the assistance of the metal ion [
86]. Flavonoids, hydroxycinnamic acids, polyphenols, flavones, and carotenoids contain heterocyclic structures with UV-vis absorption at 380 nm. The combination of organic ligands causes the spectrum to move to the red region, indicating the forming of a complex. Additionally, such antioxidants are luminous, and the difference in emissive qualities between both the free ligand and the synthesized chelate may be used to determine coordination [
91]. Organic Schiff bases are commonly utilized in the production of coordination with antioxidant effect, in addition to coordinating bioactive ingredients [
92]. The reaction of condensation between aldehydes and primary amines produces the RN = CH − R′ group, while both R and R′ are substituent function groups connected to the cores. Because the azomethine group’s N
2 atom exhibits sp
2 hybridization, it has a pair of electrons available. Furthermore, the presence of the double bond, which has an electronic donating feature and nitrogen’s low electronegativity, makes this azomethine group atom a site with high electronic density donation, therefore the Schiff bases are good ligands for the chelation with metal centers [
93,
94]. Complex formation through Schiff bases and natural antioxidants has the sequence advantages: (1) rapid and simple synthesis; (2) various methods of mechanisms; (3) the ability to use chelates as living mechanisms for antioxidant performance, and (4) significant growth in antioxidant activity relative to the complex’s free ligand [
84,
91]. Because of their antioxidant effects, metal lophthalocyanines have received increased attention. Due to the attendance of four aromatic sp
2 N
2 atoms, phthalocyanines are aromatic and macrocyclic ligands are accepted for efficiently matching for various metal centers as a chelate while the complex is formed. Furthermore, these ligands feature a conjugated 18
p-electron process, which gives them chemical resistance and stability as antioxidants [
95]. Phthalocyanines have a planar structure and are poorly soluble. To operate as antioxidants, phthalocyanines must be successfully fabricated to enhance their solubility, and these alterations did not affect their crystallinity. A great number of sequences of metal lophthalocyanines were reported in this regard. The position of the metal center of reference to the ligand’s mean plane governs the structural arrangement for this family of metal complexes [
96,
97]. The majority of the items in this article are chelates containing natural products, phthalocyanines, and Schiff bases. Several samples of nanoparticles are also presented to display why inorganic materials in general may be used as antioxidant compounds in a variety of ways. Moreover, samples of chelation improving, or not improving, antioxidant activity are shown throughout. Furthermore, studies of chelation improvements, or degrading antioxidant performance, are provided throughout this article. As can be seen, the variation in antioxidant activity of free to coordinating ligands is driven by the presence of metal, oxidation state, shape, and how the ligands link to the central metal atom.
7. Overview of Metal Chelates as an Antioxidant
Aljohani et al. (2022) prepared a new sequence of bioactive series, through the novel Schiff base ligand HNQ (1-Quinolin-8-yliminomethyl-naphthalen-2-ol) (1). CHN, conductivity, IR, magnetic moment, NMR, TGA, as well UV-Vis, were applied to explain the chemical structure. Due to this, a proper geometry had been planned for each chelate as shown in (
Scheme 1). In addition, the antioxidant performance of the tested compounds (1–5) was studied in vitro, and the data exposed that the ligand’s performance was comparable to which of the standard drug, as shown in
Figure 4. This assay was reinforced through various theoretical studies. Biological reproduction was implemented by Pharmit link to examine the drug-like molecules and to determine the degree of binding with DNA-protein (1 bna). Moreover, MOE-docking was applied to put a perfect view of the contact features among the tested compounds and 1 bna protein. The model study exposes the importance of the HNQ (1) ligand towards the DNA and the insignificant role of chelates, which was estimated. When associating in vitro through in silico data, this variance was observed, which may propose that an occurrence of any indefinite process enhances the performance of chelates in living cells [
140].
Sumathi S (2022) prepared an organic ligand through the interaction of amino acid (L-Histidine) with salicylaldehyde and 1, 10 phenanthroline (6), as well its metal chelates of [ML1L2] 7–10 (wherever M = Cd(II), Cu(II), Co(II), and Zn(II)) prepared as presented in (
Scheme 2) and were screened for in vitro antioxidant activity through DPPH and H
2O
2 tests. The obtained data are displayed in
Table 1. Cd
2+ chelate had the maximum antioxidant scavenging performance among the tested metal chelates with 86.06% and 84.64% through the DPPH and H
2O
2 methods, respectively [
137].
Nongpiur et al. (2022) studied the reaction of [(arene)MCl
2]
2 through bidentate 4-, 5-diazafluorene-9-one (dafo) and resulting organic ligands (L1–L3) (11–13) in the existence of (NH
4)[PF
6] yielded cations chelates having general formula [MLCl(arene)]PF
6 {M = Ru, arene = benzene (14, 16, 18); M = Ru, arene =
p-cymene (15, 17); M = Rh, arene = Cp* (19, 20, 21); M = Ir, arene = Cp* (22, 23, 24); [4,5-diazafluorene-9-one (L1) (11), N-(4,5-diazafluoren-9-ylidene)aniline (L2) (12), N-(4,5-diazafluoren-9-ylidene)phenyl hydrazine (L3) (13)] (
Scheme S1).To evaluate the biological efficacy of tested compounds, antioxidant experiments were screened. The tested compounds also had significant antioxidant action against DPPH radicals, according to the results. Antioxidants could interact with extra free radicals by meddling through the oxidation procedure, similarly through substitutes as sensitive type scavengers. DPPH scavenging technique is extensively used to control antioxidant performance. The radical scavenging capability (%) for the tested free ligands and their chelates was identified as related to the radical scavenging outcome by DPPH with ascorbic acid as a reference; the values are shown in
Table 2. The data displays that the tested compounds showed noticeable radical scavenging performance [
141].
Priya J and Madheswari D (2022) developed a new organic ligand (25), in combination with the usage of less-expensive elements, through significant therapeutic potential and have prompted huge interest in the growth of organic ligands. Thus, four various metal chelates comprising Mn
2+ and Ni
2+ and Cd
2+ and Pb
2+ (considered as chelates 26–29) were prepared through a new tetra-dentate organic ligand (L) (25), obtained through condensation of (3,5-dichlorosalicylaldehyde and trans-1,2-diaminocyclohexan, as proven here (
Scheme S2). Research on the free radical scavenging applied by the ligand L (25) and the studied metal chelates (26–29) showed that the Ni(II) chelate had more effectiveness. The antioxidant values are displayed in
Table 3 [
142].
Elaaraj et al. (2022) prepared novel metal chelates of Zn
2, Co
2+, Ni
2+, and Cu
2+ derived from the ligand 2-(thiophene-2- yl)-1-(thiophen-2-ylmethyl)-1H-benzo [d] imidazole. The antioxidant performance for tested ligand, as well the tested chelates estimated by DPPH process, were compared to the standard antioxidant. The data obtained exhibited that the antioxidant performance of the tested ligand, as well as their chelates, were moderate and that the Cu(II) chelate had a great performance, outdoing ascorbic acid. We could determine that the chelation of the tested ligand stimulated the antioxidant performance. The antioxidant performance considerably improved for the electron-withdrawing effect of the M
2+ ion, which simplified the issue of H
2 to decrease the DPPH radical [
143].
Gur’eva et al. (2022) prepared a new substance from Cu(II) chelates (30–33) with terpene products of ethylenediamine (34–35) (
Figure S1), the results of reviewing their antimicrobial and antioxidant performance in vitro are debated. All calculated Cu(II) chelates (30–33) exhibited considerably greater antifungal action than the strains of S. salmonicolor, C. Albicans, P. notatum, which were associated with the motion of the scientific antifungal amphotericin drug. Great antibacterial performance for Cu(II) chelates with terpenes of ethylenediamine was demonstrated in relation to the S. aureus strain (MRSA), which is strong against the standard antimicrobial ciprofloxacin. Via several experiment systems, a relative calculation of the antioxidant performance of the prepared Cu(II) chelates and the organic ligands was accepted. As shown in
Figure 5 the salen-type chelate four had the maximum antioxidant performance in the typically introduced oxidation for a substrate covering lipids greater for other Cu(II) chelates in terms of the capability of keeping erythrocytes below surroundings of H
2O
2-induced hemolysis. As shown in
Figure 6 [
144].
Devi et al. (2022) prepared multiple Cu(II), Co(II), Zn(II), and Ni(II) chelates through four Schiff organic ligands (BHAP) (36), BHACM (37), BHACN (48), and BHIMP (39) gained through the reaction of 4-(benzyloxy)-2-hydroxybenzaldehyde with several aminophenols and were considered through many spectral techniques as represented in
Scheme S3. The tested substances (from 36 to 55) were estimated for their antioxidant performance in vitro then found that the prepared M
2+ chelates were very powerful, displaying proficiency for decolorizing the purple solution of DPPH related to free ligands. Cu-chelates had the highest potency, with IC
50 data as 2.98 toward 3.89 μM range. As represented in
Table 4, the MOD of organic ligand BHACM (37) and its copper-chelate with enzyme; C. Albicans sterol 14-alpha demethylase recommended the hydrophobic binding. Moreover, in silico test strained which meant the tested materials could be utilized as orally active drugs [
145].
Ali et al. (2022) synthesized heterocyclic chelates of Cr(III) and Fe(III) by reducing succinic dihydrazide with 5-chloroindoline-2, 3-dione in an aqueous medium through the original technique in (1:1:1) proportion with M.W irradiation system (
Scheme S4). The tested chelates were strained toward bioactivity. Anticancer performance was assessed in relation to the HNSC cells line and antioxidant performance is completed through the DPPH test. All tested compounds (56–59) exhibited free radical scavenging activity. [Cr(C
12H
10N
5O
2Cl) (NO
3)
2]NO
3 chelate presented maximum free radical scavenging activity (IC50 ≥ 50 μg) between all of the studied chelates in association with BHA (IC
50 ≤ 50 μg). An in silico test was completed through MOD with EGFR tyrosine kinase. The results displayed which tested materials had substantial anticancer and antioxidant performance [
146].
Arciszewska et al. (2022) said that caffeic acid (CFA(60)) and its anion caffeinate (L3−) (61) are just one of many bioactive components and chemo-preventive agents based on human nutrition. Their metallic chelates are also vital in living processes. However, research on the characteristics of CFA with inorganic metals is extremely uncommon, thus very little live or ecological data is revealed about all of these operating processes. The preponderance of their property, including physiological development and environmental influence, depend greatly on their structure, stability, and solution behavior. These interactions for the Eu(III)/CFA chelate were investigated using a multi-analytical-system strategy. The main molecular formula of the investigated metal chelate in the solid state was [Eu(CFA)
3 (H
2O)
3]·2H
2O (M:L ratio 1:3) (62), though the 1:1 forms were discovered in an aqueous medium at the optimal pH of 6 pH 10 ([Eu(CFA)] and [Eu(CFA)(OH)]) (
Scheme 3). Electrochemical mobility tests were performed to analyze the interaction of Eu(III)/CFA (62) and CFA primarily across the cellular membrane. Multiple antioxidant studies have indicated that Eu(III)/CFA has less antioxidant action than pure CFA ligands. As a result, we used five free antioxidant techniques to demonstrate that Eu(III) did neither disrupt nor diminish CFA’s antioxidant effects (
Figure 7). The IC
50 for Eu(III)-caffeinate could not be determined using the DPPH approach because it precipitated at a higher concentration. In CUPRAC and FRAP tests, Eu(III)/CFA chelate showed decreasing assets, although lower than CFA (CUPRAC assay: 285.08 and 343.99 Trolox equivalence; FRAP biomarker: 15.79 and 18.24 mo·dm
3 of Fe
2+ for Eu(III)-caffeinate and the CFA chelate and CFA, respectively [
139].
MedetalibeyogluH (2022) studied and synthesized the antioxidant activity of (EPM)2-ethoxy4-[(5-oxo-3-phenyl-1,5-dihydro-1,2,4-triazol-4-ylimino)-methyl]-phenyl-4-meth oxybenzoate (
Scheme S5). The tested EPM (63) material was positively prepared through new resultant naturally significant 1-, 2-, and 4-triazole ligands. This study of 1-, 2-, and 4-triazole ligands had extended from the condensation of 3-phenyl-4-amino-4, 5-dihydro-1H-1, 2, 4-triazole-5-one and 2-ethoxy-4 -formylphenyl-4-methoxybenzoate. The antioxidant activities for the investigated organic ligands were estimated by applying the Dinis, Oyaizu, and Blois methods. The studied metal chelating performance for the novel prepared ligand and reference detected for the reduction in the order of α-tocopherol < EPM < EDTA was in agreement with the Dinis process. The tested synthesized organic ligand exhibited NLO stuff, which was 34 periods, as considerable as the feature of urea. The ability of H
2 or e
− donation for EPM and Ascorbic acid, such as BHA, BHT, and α–tocopherol was projected through the DPPH. In this respect, the result exposed that the tested prepared EPM had not reported effective activity as a radical scavenger and did not have H
2 donor performance. The EPM results demonstrated a definite Fe-binding potential, suggesting that their purpose as peroxidation protections might be linked to their iron-binding ability. The studied metal chelating performance of EPM and standards was studied toward decline into the demand of α-tocopherol < EPM < EDTA, which were 39.0%, 53.2%, and 85.7% at the final absorption, correspondingly [
147].
Damena et al. (2022) studied novel [Co(L)(Cl) (H
2O)
2] (65) and [V(L)(O) (H
2O) (SO
4)] (66) chelates prepared from an (E)- 2-(((2-((2-hydroxyethyl)amino)quinolin-3-yl) methylene) amino)ethan-1-ol ligand C
14H
17N
3O
2 (64), CoCl
2·6H
2O and VOSO
4 in Me OH solutions (
Scheme S6). The antioxidant action of prepared ligands, as well as their metal chelates, were evaluated in vitro through DPPH. The organic ligand displayed fewer in vitro antioxidant performances than the tested chelates, whereas the Co chelate had a superior antioxidant performance through half-inhibitory concentrations (IC
50 of 16.01 μg/ mL) than the free ligand, (VO) chelate. MOD study also recommended a lot of attention to the biological performance of the tested Co and VO chelates. Accordingly, molecules that have an antioxidant action could decrease the absorbance at 517 nm; this is related to the DPPH assay shifting hue during the recombination process [
148].
Abu-Dief et al. (2022) prepared Fe(III), Cr(III), and Cu(II) chelates (68–70) with high yields through the reaction of aryl hydrazone ligand (DPHB) (67) with metal ions as shown in
Scheme 4. Additionally, the new metal chelates have been tested anti-pathogenically and instituted to be considerably effective and associated with the equivalent DPHB ligand. The anti-proliferative performance of the tested molecules was also estimated at various positions of cancer cells and displayed vital cytotoxic performance. In addition, explanations of antioxidant performance propose that antioxidant performance comparative to usual vitamin C was verified in the molecule. As shown in
Figure 8 [
149].
Qasem et al. (2022) prepared a new series of bis-hydrazone chelates from (N′E,N‴E)-2,2-(1,3-phenylenebis(oxy))bis(N′-(4,5-di-tert-butyl-2-hydroxybenzylidene)acetohydrazide) ligand (SB) (71) with Co
2+, Cu
2+, Zn
2+ and Ni
2+ ions (72–75), as shown in
Scheme 5. Furthermore, the MTT test was applied to display the newly tested compounds towards a variety of cell lines. The antioxidant performance of the studied compounds in DMSO was estimated through the DPPH technique. These values show that the SB ligand and its metal complexes have a higher antioxidant performance, and the efficiency % of inhibitions for the tested compounds is represented in
Figure 9. This decision was further corroborated by the fact that the tested chelates had similar antioxidant performance to the DPPH free radical with the reference Vitamin C. The in silico data display the low performance of the free ligand that enhanced the chelation with the Cu(II), in contrast with the practical data [
150].
Sen et al. (2022) reported various requests for metal-based phenalenyl chelates, such as biological implications for metal-PLY (metal = Mn
3+, Co
2+, Fe
3+, Al
3+, and Ni
2+) processes that are still to be identified (
Figure S2). Metal-PLY (76–80) chelates were found to have acceptable antioxidant capabilities in the DPPH scavenging method. The scavenging % also improved through concentration. The Mn-PLY 2 chelate was closest to the reference ascorbic acid between the metal-PLY chelates and had the greatest antioxidant activity. For the metal-PLY chelates (
Table 5), we decided that the IC
50 data were in the demand of ascorbic acid (reference) > Mn-PLY (76) > Co-PLY (80) > Fe PLY (78) > Ni-PLY (79). Mn-PLY (76) demonstrated better antioxidant activity than other metal-PLY chelates, which could be due to the Mn
3+/Mn
2+ redox potential. Otherwise, ligands for the Mn-PLY (76) chelate might require improving the electron donation capability for the studied compound [
151].
Parcheta et al. (2021) used several studies and the extensive literature statistics to indicate that ligand antioxidant abilities complexes with metals could have a considerable impact on radicals’ complex formation. Agreeing with their primary ideas with clarity, this effectiveness is enriched mainly with metals with strong ion potential, e.g., Cr
3+, Fe
3+, Ln
3+, and Y
3+. Chelates with molecular orbitals’ electrical charge are more effective antioxidants. The obtained measurements of antioxidant activities, such as DPPH and ferric reduced ability potential test (FRAP), were related to thermodynamic factors calculated using analytical modeling. Using experimental data obtained, the pathways of free radical formation were characterized. The HOMO energy transfer in benzoic acid derivatives changed as the number of OH groups increased. Flavonoids’ antioxidant capabilities were highly influenced by the OH group location as well as the catechol group. The number of OCH
3 groups in phenolic acid molecules affected antioxidant performance. The use of radiation methods in the electrical structure investigation of antioxidants was planned [
152].
Mucha et al. (2021) evaluated a wide range of plant substances and their coordination compounds for their antioxidative, anti-inflammatory, anticancer, and other therapeutic effects. Because of their structural differences, flavonoids, chromones, and coumarins, as well as their coordination compounds (81–86), have diverse bioactivities (
Figure 10). As well as providing an overview of the most studied antioxidant effects of such compounds, this review covers both endogenous and exogenous forms of ROS and NOS, oxidative stress-mediated lipids and peptide degradation, and the therapeutic effects of antioxidant defense systems, including plant-derived antioxidants [
153].
Turan et al. (2021) studied the antioxidant and enzymatic inhibition properties of a new drug ligand as well as its metallic chelates. The new chemical ligand (((E)-6-tert-butyl 3-ethyl 2-(2-hydroxybenzylideneamino)-4,5-dihydrothieno [2,3-c]pyridine-3,6(7H)-dicarboxylate) [TBHPC] (87) was generated by combining 6-tert-butyl 3-ethyl 2-amino-4,5-dihydrothieno [2,3-c]pyridine-3,6(7H)-dicarboxylate with 2-hydroxy benzaldehyde. The metal chelates of the unusual organic ligands Fe(II), Co(II), and Ni(II) (88–90), as shown in (
Scheme S7), were produced and described. In vitro antioxidant methodology experiments indicated that the obtained ligand had more potent antioxidant properties than its metal chelates; however, it also had a smaller total antioxidant potential than common bioactive components. In vitro enzymatic-acting techniques were employed to assess the inhibitory activity possibility of the tested samples for AChE, BChE, and GST enzymatic. The chemical ligand was demonstrated to be the most specific inhibitor of AChE and BChE, with Ki values of 7.13 ± 0.84 μM and 5.75 ± 1.03 μM, correspondingly. Furthermore, the K
i values for the GST enzyme were 9.37 ± 1.06 μM for the Fe(II) chelate. Finally, the metallic chelates verified superior critical attractions with the AChE, BChE, and GST enzymes than for the organic ligand, as demonstrated in
Table 6. This work identified a promising natural base ingredient for AChE and BChE that aims to further investigate the in vivo and safety prediction [
154].
Abu Dief et al. (2021) prepared a series of novel chelates resulting from Cu
2+, Pd
2+, and Fe
3+ ions interacting through CPTP (91) thiazole derivative ligand. In in vitro tests, the antioxidant performance of studied compounds was screened. All chelates revealed control than free ligand ineffective behavior, particularly the CPTPPd (92) compound (
Scheme S8). MOE-docking simulation and drug-likeness resulted in directly favorable inhibitory properties of CPTPPd and CPTPCu (93) chelates, in contrast with in vitro results. The findings suggested enhanced antioxidant efficacy compared that of the tested ligand, as it improved as the level of the examined molecule raised. With regards to IC
50, the analysis indicated that CPTPFe (94) had a powerful antioxidant ability with only an IC
50 value of 31 g/mL, which is not far from that of ascorbic acid [
155].
Abu Dief et al. (2021) synthesized new pharmacologically active chelates from the reaction of Pd
2+, Fe
3+, and Cu
2+ ions with 2-amino-6- oxo-3-(piperidinylamidino)-4 -(4methoxyphenyl)-6, 7-dihydro-pyrano[2,3-d]-5,7thiazol ligand (MPTP) (95), as shown in
Scheme 6. In silico test was performed through two various methods over molecules to estimate their biological performance and grade for contact with biological structures. The MPTPPd chelate showed its importance in contact with amino acid residues and drug-like features. Antioxidant performance was studied and the chelates displayed high reactivity toward trapped free radicals (
Figure 11). Such chelates (96–98) could be measured as favorable bioactive agents. The DPPH assessment presented scavenging ability for studied compounds; though, we need to evaluate the IC
50 results to study their actual control of them. Thus, scavenging capabilities for the studied molecules were assessed for the color decay grade of DPPH [
156].
Alzahrani et al. (2021) synthesized new bioactive chelates from the reaction of Cu
2+, Fe
3+, and Pd
2+ ions through PTP (99) ligand [2-amino-6-oxo-3-(piperidinylamidino) -4-phenyl 6,7-dihydro-pyrano [2,3-d]-5,7-thiazol], as shown in
Scheme 7. The ligand performed as a bidentate ligand through all metals inside (1 L:1 M) equimolar ratio. Additionally, antioxidant activity was studied and the chelates exhibited significant antioxidant performance. The tested ligand (99) and its chelates (100–102) were studied through the DPPH test, and the values pointed to vital antioxidant performance associated with standard drugs. The experiment was performed under various concentrations from the tested compound and the data were represented. As shown in
Figure 12, more radical-scavenging performance of DPPH was related to minor IC
50 data. The chelates presented a vital antioxidant performance that was greater than the standard medicine. That might be associated with the coordination structure or redox environments. Moreover, the MOE docking approach clarifies all contact properties that occurred by 2 k4 l protein, which agrees through in vitro values [
157].
Xu et al. (2019) applied the tested compounds in botanic therapy and traditional Chinese therapy as a result of their effective antioxidant performance. In current years, the antioxidant performance of quercetin has been tested widely, containing its properties on glutathione (GSH), ROS, enzymatic performance, and signal transduction paths affected by green and toxicological features. Chemical tests on quercetin have mainly intensive on the antioxidant performance of its metal chelates and complex ions (
Figure 13) displays the antioxidant indication paths controlled through quercetin [
158].
Abo afia et al. (2018) prepared and characterized new VO, Zn, Mo, Ru, and Pd chelates (
Figure 14). Analytical results exhibited that H
2dhbh ligand performed as a monobasic or dibasic tri-dentate ligand through phenolate O, azomethine N and amide O to afford [VO
2(Hdhbh)] (103), [VO(Hdhbh)(Phen)]·1.5H
2O (104), [Zn(Hdhbh)
2] (105), [MO
2(dhbh)H
2O] (106), [MO
2(dhbh)CH
3OH] (107), [Ru(PPh
3) (dhbh)Cl (H
2O)] (108) and [Pd(Hdhbh)Cl] (109) complexes. The antioxidant performance of the tested complexes was assessed in relation to the DPPH radical, and it has been initiated that VO(IV) complex (104) demonstrated the maximum radical scavenging effectiveness equivalent to ascorbic acid as a reference antioxidant. The DNA binding assets of the tested compounds have been studied through electronic spectra with DNA cleavage through gel electrophoresis. The values presented in
Figure 15 also show that V(IV) chelate (104) had a vital oxidative cleavage between other chelates [
159].